Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.

Eun Sang YiMeong Hi SonJu Kyung HyunHee Won ChoHee Young JuJi Won LeeKeon Hee YooKi Woong SungHong Hoe Koo

Published in: Pediatric blood & cancer (2019)

The results suggest that a higher serum NSE level at relapse/progression is a predictor of worse prognosis in patients with response failure to tandem HDCT/auto-SCT, and that incorporation of HD-MIBG treatment into allo-SCT may improve outcomes.

Keyphrases

high dose
stem cell transplantation
low dose
free survival
bone marrow
cell therapy
stem cells
locally advanced
mesenchymal stem cells
smoking cessation
chemotherapy induced